Translational Approach of Using Ex Vivo Cytotoxicity and Early Clinical Data to Predict Teclistamab Efficacious Therapeutic Range in Multiple Myeloma Patients

被引：1
|
作者：
Girgis, Suzette
Lin, Shun Xin Wang
Pillarisetti, Kodandaram
Banerjee, Arnob
Goldberg, Jenna D.
Shetty, Shoba
Stephenson, Tara
Hilder, Brandi W.
Hanna, Brett
Smit, Jennifer
Adams, Homer, III
Sun, Yu-Nien
Infante, Jeffrey R.
Elsayed, Yusri A.
Sharma, Amarnath
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-140565
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 45 条
  • [1] Translational Modeling Predicts Efficacious Therapeutic Dosing Range of Teclistamab for Multiple Myeloma
    Suzette Girgis
    Shun Xin Wang Lin
    Kodandaram Pillarisetti
    Arnob Banerjee
    Tara Stephenson
    Xuewen Ma
    Shoba Shetty
    Tong-Yuan Yang
    Brandi W. Hilder
    Qun Jiao
    Brett Hanna
    Homer C Adams
    Yu-Nien Sun
    Amarnath Sharma
    Jennifer Smit
    Jeffrey R. Infante
    Jenna D. Goldberg
    Yusri Elsayed
    Targeted Oncology, 2022, 17 : 433 - 439
  • [2] Translational Modeling Predicts Efficacious Therapeutic Dosing Range of Teclistamab for Multiple Myeloma
    Girgis, Suzette
    Lin, Shun Xin Wang
    Pillarisetti, Kodandaram
    Banerjee, Arnob
    Stephenson, Tara
    Ma, Xuewen
    Shetty, Shoba
    Yang, Tong-Yuan
    Hilder, Brandi W.
    Jiao, Qun
    Hanna, Brett
    Adams, Homer
    Sun, Yu-Nien
    Sharma, Amarnath
    Smit, Jennifer
    Infante, Jeffrey R.
    Goldberg, Jenna D.
    Elsayed, Yusri
    TARGETED ONCOLOGY, 2022, 17 (04) : 433 - 439
  • [3] Correction: Translational Modeling Predicts Efficacious Therapeutic Dosing Range of Teclistamab for Multiple Myeloma
    Suzette Girgis
    Shun Xin Wang Lin
    Kodandaram Pillarisetti
    Arnob Banerjee
    Tara Stephenson
    Xuewen Ma
    Shoba Shetty
    Tong-Yuan Yang
    Brandi W. Hilder
    Qun Jiao
    Brett Hanna
    Homer C. Adams
    Yu-Nien Sun
    Amarnath Sharma
    Jennifer Smit
    Jeffrey R. Infante
    Jenna D. Goldberg
    Yusri Elsayed
    Targeted Oncology, 2022, 17 : 609 - 609
  • [4] Translational Modeling Predicts Efficacious Therapeutic Dosing Range of Teclistamab for Multiple Myeloma (June, 10.1007/s11523-022-00893-y, 2022)
    Girgis, Suzette
    Lin, Shun Xin Wang
    Pillarisetti, Kodandaram
    Banerjee, Arnob
    Stephenson, Tara
    Ma, Xuewen
    Shetty, Shoba
    Yang, Tong-Yuan
    Hilder, Brandi W.
    Jiao, Qun
    Hanna, Brett
    Adams, Homer C., III
    Sun, Yu-Nien
    Sharma, Amarnath
    Smit, Jennifer
    Infante, Jeffrey R.
    Goldberg, Jenna D.
    Elsayed, Yusri
    TARGETED ONCOLOGY, 2022, 17 (05) : 609 - 609
  • [5] Ex vivo expanded autologous natural killer cells as a novel therapeutic approach in multiple myeloma
    Alici, Evren
    Sutlu, Tolga
    Bjokstrand, Bo
    Gilljam, Mari
    Stellan, Birgitta
    Nahi, Hareth
    Quezada, Hernan Concha
    Gahrton, Gosta
    Ljunggren, Hans-Gustaf
    Dilber, M. Sirac
    HUMAN GENE THERAPY, 2008, 19 (10) : 1183 - 1183
  • [6] Ex vivo drug response heterogeneity reveals personalized therapeutic strategies for patients with multiple myeloma
    Kropivsek, Klara
    Kachel, Paul
    Goetze, Sandra
    Wegmann, Rebekka
    Festl, Yasmin
    Severin, Yannik
    Hale, Benjamin D.
    Mena, Julien
    van Drogen, Audrey
    Dietliker, Nadja
    Tchinda, Joelle
    Wollscheid, Bernd
    Manz, Markus G.
    Snijder, Berend
    NATURE CANCER, 2023, 4 (05) : 734 - +
  • [7] Ex vivo drug response heterogeneity reveals personalized therapeutic strategies for patients with multiple myeloma
    Klara Kropivsek
    Paul Kachel
    Sandra Goetze
    Rebekka Wegmann
    Yasmin Festl
    Yannik Severin
    Benjamin D. Hale
    Julien Mena
    Audrey van Drogen
    Nadja Dietliker
    Joëlle Tchinda
    Bernd Wollscheid
    Markus G. Manz
    Berend Snijder
    Nature Cancer, 2023, 4 : 734 - 753
  • [8] Ex Vivo Mathematical Myeloma Advisor (EMMA) - a Clinical, Molecular, and Phenotypic Platform to Tailor Personalized Therapeutic Strategies for Multiple Myeloma
    Renatino-Canevarolo, Rafael
    Silva, Maria
    Meads, Mark B.
    Zhao, Xiaohong
    Achille, Alexandra
    Noyes, David
    Sudalagunta, Praneeth Reddy
    Alugubelli, Raghunandan Reddy
    Lastorino, Daniel
    Tordesillas, Leticia
    Fontela, Miguel Gomez
    Hampton, Oliver
    Abate-Daga, Daniel
    Shain, Kenneth H.
    Silva, Ariosto Siqueira
    BLOOD, 2023, 142
  • [9] Ex-Vivo Testing Platform to Predict Clinical Response and Resistance to Proteosome Inhibitors, IMiDs and Daratumumab in Multiple Myeloma
    Marin, Constanza
    Nicola, Maribel
    Andino, Diego
    Laura Bernaschini, Maria
    Conrrero, Agustina
    Ferreira, Gimena
    Piaggio, Marisa
    Remaggi, Guillermina
    Sol Jarchum, Maria
    Jarchum, Gustavo
    Meneces Bustillo, Rodrigo
    de los Milagros Rossi, Blanca
    Jose Garcia, Juan
    Zaki, Tarek Ali
    Llorens, Candelaria
    Gatti, Gerardo
    Arroyo, Daniela
    Soria, Gaston
    BLOOD, 2023, 142
  • [10] A Multiomic Approach to Reversing Therapy Resistance in Multiple Myeloma Using Paired Ex Vivo Drug Sensitivity Measures and RNA Sequencing Data
    Sudalagunta, Praneeth Reddy
    Meads, Mark B.
    Renatino-Canevarolo, Rafael
    Siqueira Silva, Maria L. Coelho
    Zhao, Xiaohong
    Waldron, Rhett
    Cubitt, Christopher
    Alugubelli, Raghunandan Reddy
    De Avila, Gabriel
    Hampton, Oliver
    Gatenby, Robert
    Baz, Rachid C.
    Shain, Kenneth H.
    Silva, Ariosto Siqueira
    BLOOD, 2022, 140 : 4245 - 4246
12345